Raymond James Financial Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price

robot
Abstract generation in progress

Raymond James Financial has increased its price target for CME Group (NASDAQ:CME) stock from $310 to $320, maintaining an “outperform” rating, indicating a potential 4.37% upside. This positive forecast follows CME’s recent earnings beat with an EPS of $2.77 against estimates of $2.75, coupled with 8.1% revenue growth. While analysts generally assign a “Moderate Buy” rating with a consensus target of $304.65, insider transactions show recent sales of 8,539 shares, though institutional ownership remains high at 87.75%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin